SCHEMBL30962848

SCHEMBL30962848

COc1nc(Nc2ccc(OC3CCN(C)CC3)c(C)c2)nc(-c2c(Cl)ccc(O)c2C)c1C(N)=O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSP90AA1 P07900 3/20 0.37
▸ HSP90AB1 P08238 3/20 0.37
▸ EGFR P00533 4/20 0.37
▸ ERBB2 P04626 3/20 0.37
▸ ALK Q9UM73 2/20 0.37
▸ TYRO3 Q06418 2/20 0.37
▸ MERTK Q12866 2/20 0.37
▸ JAK2 O60674 1/20 0.37
▸ ABL1 P00519 1/20 0.37
▸ NTRK1 P04629 1/20 0.37
▸ LCK P06239 1/20 0.37
▸ NPM1 P06748 1/20 0.37
▸ CSF1R P07333 1/20 0.37
▸ LYN P07948 1/20 0.37
▸ RET P07949 1/20 0.37
▸ ROS1 P08922 1/20 0.37
▸ PDGFRB P09619 1/20 0.37
▸ FGR P09769 1/20 0.37
▸ KIT P10721 1/20 0.37
▸ BCR P11274 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30962590 0.96 UTS2R (0.38) HSP90AA1HSP90AB1EGFRERBB2ALK
SCHEMBL30962652 0.91 EGFR (0.42) EGFRERBB2ALKTYRO3MERTK
Formic Acid SCHEMBL30962939 0.88 EGFR (0.40) EGFRERBB2ALKTYRO3MERTK
SCHEMBL30962572 0.88 WEE1 (0.41) ALKJAK2RETROS1FLT3
SCHEMBL30962825 0.87 EGFR (0.40) EGFRERBB2ALKFGFR1KDR
SCHEMBL30962809 0.83 EHMT2 (0.37) ALKJAK2EHMT2
SCHEMBL30962668 0.82 WEE1 (0.41) ALKJAK2RETROS1SRC
SCHEMBL30962775 0.82 ALK (0.42) ALKJAK2CSF1RCAMK2DEHMT2
SCHEMBL30962965 0.81 JAK3 (0.42) EGFRRETSRCKDRSYK
SCHEMBL30962846 0.80 PTK2 (0.41) EGFRALKCSF1RRETFGFR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4642767-A1 PYRIMIDINE CARBOXAMIDE COMPOUNDS Acrivon Therapeutics, Inc. (US) 2025-11-05 — — EP disclosed
WO-2024145505-A1 PYRIMIDINE CARBOXAMIDE COMPOUNDS ACRIVON THERAPEUTICS, INC. (US) 2024-07-04 — — WO disclosed
Send feedback